MALAT1 and central nervous system cancer: Meanwhile, the percentage of EdU positive cells in si‐MALAT1 group also dramatically declined, suggesting that knockdown of MALAT1 could significantly repress the proliferation of glioma stem cells (Figure 2C,D, both P < .01).